Cornerstone Genomics, founded in 2017 and headquartered in Frederick, Maryland, is dedicated to providing expert advisory services on the use of genomic tools across various fields including human disease, biomedicine, veterinary sciences, and wildlife research. The company’s flagship product, CodeXome, is a cutting-edge cloud platform that facilitates rapid genetic data analysis, enabling researchers to uncover novel insights by examining DNA variants through an evolutionary perspective.
Cornerstone Genomics has made significant strides in advancing genetic discovery, leveraging CodeXome to transform complex genomic data into actionable insights. The platform's ability to reveal key diagnostic markers has positioned the company as a leader in the genomics advisory space. Through its innovative approach, Cornerstone Genomics continues to impact the fields of biomedicine and wildlife research, driving forward the understanding of genetic information and its applications.
